Goodrx is trading 5% down at $3.34, primarily as healthcare stocks sell off amid concerns over insurance coverage, subsidy expirations, and rising industry pressure.
- It is below its recent $3.52 close on September 8, 2026.
- No new company-specific earnings, guidance, regulatory action, or analyst catalyst was identified on September 9; the latest announcement was the September 3 Companion Family Plan launch, and results and guidance were released August 5.
- Trading remains active during the open session, with broader risk sentiment also negative.